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Abstract
Background: We report unfavorable outcome in a patient with subretinal granuloma caused by dual infection of
Mycobacterium tuberculosis complex with Mycobacterium fortuitum and Mycobacterium bovis in an immunosuppressed,
non-HIV patient. We did a systematic review of literature on dual infection due to M. tuberculosis and M. fortuitum via
MEDLINE and PUBMED and could not find any case reported of causing this kind of dual infection in the eye.
Results: A 38-year-old Indian male patient presented with decreased vision in the left eye for 3 months, diagnosed as
tubercular choroidal granuloma with associated retinal angiomatosis proliferans (RAP) lesion. He also had multiple
enlarged lymph nodes in the chest, and sternal pus sample was positive for acid-fast bacilli (AFB). M. tuberculosis
complex was detected by gene expert. The patient was started on antitubercular treatment (ATT) whereby the lung
lesions improved but the ocular lesion showed initial clinical improvement followed by worsening. Twenty-five-gauge
diagnostic pars plana core vitreous surgery was done whereby sample demonstrated a large number of AFB on
Ziehl-Neelsen stain and auramine-rhodamine stain. The vitreous sample showed growth on routinely inoculated
mycobacteria growth indicator tube (MGIT) 960 tubes, and multiplex polymerase chain reaction (PCR), Gene Xpert
MTB/ RIF assay (Cepheid, Sunnyvale, CA), and line probe assay (LPA) were positive for ocular tuberculosis. In view
of nonresponse to conventional ATT, a suspicion of dual infection of M. tuberculosis complex with a nontubercular
mycobacteria was kept and a subculture was made onto the solid Lowenstein-Jensen (LJ) medium from the positive
MGIT 960 tubes. Two morphologically distinct types of colonies were obtained on LJ slopes. Subsequently, the two
etiological agents were identified as M. fortuitum and M. bovis by PCR from the vitreous sample.
Conclusions: Co-infection of M. tuberculosis complex with nontubercular mycobacterium (NTM) has never been
reported from ocular tuberculosis before. In immunosuppressed individuals, who test positive for MTB, not responding
to the standard ATT, one needs to have a high index of clinical suspicion to rule out associated NTM infection and
initiate appropriate multidrug systemic antibiotic therapy early.
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Nontubercular mycobacterium (NTM) infections are dif-
ficult to identify thus causing a delay in the diagnosis
and treatment [1]. The agents causing NTM infections
are found ubiquitously in soil, dust, and water. Human
infection is thought to be acquired from environmental
exposures [2]. In the literature, only nine cases of uveitis
caused by NTM have been reported. Of these, five were
detected in immunocompromised patients [1]. We re-
port a novel case of subretinal granuloma caused by dual
infection with M. tuberculosis complex and M. fortuitum
leading to an unfavorable outcome in a non-HIV
patient.
Case report
A 38-year-old Indian male presented with decreased vi-
sion in the left eye for 3 months. His vision was 6/6 in
the right eye and 3/60 in the left eye. The intraocular
pressure with Goldmann applanation tonometery was 16
and 18 mmHg in the right and left eye, respectively.
Examination of the right eye was normal. Examination
of the left eye revealed clear cornea with 2+ cellular
reaction, 1+ flare, 1+ vitritis, and a large elevated mass
lesion with massive exudation (Fig. 1). Fundus floures-
cein angiography revealed early blocked fluorescence in
the lesion, network of retinal vessels forming retinal
angiomatosis proliferans (RAP) lesions with late pool-
ing of dye. We kept a strong possibility of tubercular
choroidal granuloma with associated RAP lesion based
on the above clinical findings.
Patient was a farmer by occupation. Past history re-
vealed treatment with pulse dose of intravenous steroids
followed by oral steroids at 1 mg/kg body weight,
dexamethasone intravitreal implant (Ozurdex, Allergan),
and co-trimoxazole for presumed ocular toxoplasmosis.
This long-term use of systemic steroids at a high dosage
leads to an immunosuppressed state thereby leading to a
disseminated form of infection. Past investigations like
complete hemogram, VDRL, HIV, HBsAg, Toxo IgG
/IgM, and Mantoux test were normal. At our center,
examination by internist revealed normal examination
except for erythematous area with small pustule on the
sternal aspect of chest. Contrast-enhanced computed
tomography (CECT) of chest showed loculated pericar-
dial effusion in anterior part along with small foci of
subsegmental collapse and bronchiectasis in the left
upper lobe, paracardiac part of the right medial lobe
and left lingual along with few subcentimeter lymph
nodes in the right paratracheal chain. Sternal pus sam-
ple was drawn which showed acid-fast bacilli (AFB) on
Ziehl-Neelsen staining, and Mycobacterium tuberculosis
complex (MTBC) was detected by gene expert.
The patient was started on antitubercular treatment
(ATT), i.e., rifampicin 600 mg, isoniazid 300 mg, pyra-
zinamide 1500 mg, ethambutol 800 mg, and pyridoxine
10 mg. In view of presence of dexamethasone implant
(Ozurdex, Allergan), oral steroids were not given. Intra-
vitreal bevacizumab was given for RAP lesion. In the
next 2 months, there was a gradual resolution of exuda-
tive detachment with BCVA improvement. Complete
resolution of the sternal lesion was noticed. Two weeks
later, he presented with drop in vision and re-
appearance of exudation. Clinical impression of para-
doxical worsening was made. He was put on oral
steroids along with ATT owing to worsening in next
3 days despite treatment. Two weeks later, 25-gauge
diagnostic vitreous surgery was done. Large number of
AFB on Ziehl-Neelsen stain and auramine-rhodamine
stain were noticed. The conventional mycobacteria
growth indicator tube (MGIT) 960 system also showed
positive growth. The presence of MTBC was confirmed
by multiplex polymerase chain reaction (PCR) [3], Gene
Xpert, and line probe assay (LPA). It was reported as
sensitive to rifampicin by Gene Xpert and sensitive to
both rifampicin and isoniazid by LPA. On subculture
from MGIT bottle onto Lowenstein-Jensen (LJ)
medium, it grew nontubercular mycobacteria (Fig. 2a)
confirmed by acid-fast staining. Subsequently, standard
biochemical tests were carried out along with further
subculture on 2 LJ slants and Mac Conkey medium.
The organism was found to be a rapid grower and
formed tiny pink colonies on Mac Conkey (Fig. 2b).
Presumptively, the organism was identified as M. fortui-
tum using standard biochemical reactions like nitrate
reduction and 68 °C catalase. For further confirmation,
the isolate was subjected for PCR targeting M. fortui-
tum complex specific SOD gene primers and yielded a
Fig. 1 Fundus photograph of the left eye showing a large elevated
mass lesion, sparing the superior part of retina, with massive
exudation around the lesion and with an Ozurdex implant in situ
(black arrow)
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PCR product of 275 bp as described previously [4]
(Fig. 2c). For PCR, 5 ml eluted DNA from culture of M.
fortuitum and patient’s vitreous fluid (VF) sample was
used. For PCR amplification with 1× PCR buffer
(10 mM Tris with 15 mM MgCl2), 200 mM deoxynu-
cleotide, 1 mM of each primer (forward primer 5′
CCAAGCTCGATGAGGCGCGG 3′ and reverse pri-
mer 5′CCGATCGCCCAGGTCTGT3′), and 1 unit of
Taq polymerase (Bangalore Genei, Bangalore, India).
Following cycling conditions were used denaturation at
95 °C for 5 min, 35 cycles consisting of denaturation at
94 °C for 15 s, annealing at 60 °C for 15 s, and exten-
sion at 72 °C for 10 min. DNA extracted from ATCC
M. fortuitum was used as positive control, and PCR
grade water was used as negative control. Positive re-
sults yielded 275 bp PCR product in positive control,
DNA extracted from M. fortuitum culture and DNA ex-
tracted from patient’s VF as shown in Fig. 2c. PCR
product of M. fortuitum was confirmed by sequencing.
Interestingly, the subculture made onto the solid LJ
medium (Fig. 2a) from the MGIT positive tubes showed
presence of relatively moist colonies within 3 days of
incubation. These colonies of a “rapid-grower” on LJ
slopes, along with the fact that the patient was not
responding to conventional ATT, were strong pointers
towards a dual infection. The rapid grower formed tiny
pink colonies on Mac Conkey agar (Fig. 2b) and were
presumptively identified as M. fortuitum on the basis of
nitrate reduction and 68 °C catalase. They were later
confirmed using PCR targeting specific primers for M.
fortuitum [4] (Fig. 2c). When the LJ sloped were
allowed to incubate for extended period, rough buff-
colored colonies also appeared along with M. fortuitum
colonies after 14 days of incubation. As this second
etiological agent was already known to belong to
MTBC (by Gene Xpert and LPA), specific PCRs for
common agents of MTBC were carried out. It was
confirmed as M. bovis using specific Hup B gene, as
described previously [5] (Fig. 2d). On 24-locus MIRU-
VNTR typing [6], using reference database and analysis
available at www.miru-vntrplus.org, the MTBC isolate
was found to be of the CAS-Delhi type.
Oral levofloxacin 500 mg twice a day was added, since
the rapid growers like M. fortuitum is found to be sensi-
tive to flouroquinolones (third generation) in addition to
the ATT [2]. PET scan revealed intense FDG uptake in
the affected eyeball and left supraclavicular, mediastinal,
right upper, and lower paratracheal and bilateral hilar
lymph nodes. In view of the poor response to treatment,
he was investigated to rule out immunosuppression. His
CD4 count was very low (2.8%, absolute count—51/μl),
with absolute lymphocyte count of 1807/μl. Repeat HIV
and HIV-1 proviral DNA were negative. Steroids were
stopped, and ATT was continued for a total duration of
1 year. However, we were not able to save the eye ana-
tomically and functionally. At 9 months of follow-up,
the left eye had no light perception with phthisis bulbi
and the other eye was normal. Repeat PET scan revealed
no FDG uptake in the previously involved tissues. Oral
isoniazid and rifampicin were continued, while oral levo-
floxacin was stopped.
Discussion
In a highly TB-endemic country like ours, ocular tuber-
culosis is relatively not a rare entity and it occurs
mainly in the form of posterior uveitis. Early detection,
diagnosis, and appropriate conservative management
with antitubercular therapy often yield good results in
terms of preservation of vision and restoration of ana-
tomical integrity [7]. Our patient had a large tubercular
choroidal granuloma, which tested positive on Ziehl-
Neelsen staining and PCR, but with a poor clinical
Fig. 2 a Formation of moist colonies on LJ medium seen within 3 days of incubation. b Tiny pink colonies formed by the rapid growers on
Mac Conkey agar. c Presence of M. fortuitum confirmed by using PCR targeting specific primers for M. fortuitum. L1—100 bp molecular marker,
L2—275 bp positive control of M. fortuitum (black arrow), L3 and L4—DNA extracted from culture and positive for M. fortiuitum, L5 and L6—DNA
extracted from patient VF sample positive for M. fortuitum, L7—negative control. Presence of M. fortuitum confirmed by using PCR targeting
specific primers for M. fortuitum (black arrow). L1—100 bp MM, L2—positive control (black arrow), L3 and L4—DNA extracted from culture isolate
from VF sample of patient, L5—DNA extracted from VF sample of patient, L6—negative control. d Presence of M. bovis confirmed by using PCR
targeting the specific Hup B genes. L1—100 bp MM, L2—positive control for M. bovis (black arrow), L3 and L4—DNA extracted from culture of M.
tuberculosis complex, L5—DNA extracted from VF of patient sample, L6—negative control
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outcome despite initiating ATT. An important reason
for the poor outcome could be infection due to the
multidrug resistant M. tuberculosis, which was ruled
out, by the LPA and Gene Xpert in our case. Gupta et
al. [7] hypothesized that puncturing the granuloma/ab-
scess leads to dissemination of the organisms into the
vitreous cavity followed by the development of endoph-
thalmitis that may not be amenable to treatment and
may eventually require evisceration. Biswas et al. [8] re-
ported relatively worse outcome in the eyes subjected
to pars plana vitrectomy and drainage of the abscess.
However, no attempt was made to either drain or punc-
ture the granuloma during pars plana vitrectomy (PPV)
in our case. Thus, we re-evaluated our case to find out
the possible causes, and the samples that we obtained
during PPV were again subjected to cultures and mo-
lecular diagnostics. Our patient now tested positive for
a NTM along with M. tuberculosis complex on LJ
medium, which was confirmed by PCR. Thus, the pres-
ence of dual infection and delay in its diagnosis could
be the cause for poor outcome in this case. This could
have further been worsened by the concomitant use of
intravenous steroids, oral steroids, and dexamethasone
implant resulting in low CD4 counts and a dissemi-
nated form of infection.
NTM infections are rare, mainly seen in the immuno-
compromised individuals and often leading to dissem-
ination in the absence of appropriate treatment. In the
literature, NTM has been shown as a cause for choroi-
ditis in six eyes, iridocyclitis in one eye, and granuloma-
tous panuveitis in two eyes and treatment with steroids
was implicated as a risk factor in 42.9% of the cases [1].
There are four groups of NTM, among which, group
IV, i.e., the rapid growers (including M. fortuitum), is
the one most commonly infecting the eye as was seen
in our case. They do not respond to conventional ATT
alone and require a prolonged therapy with multidrug
parenteral antibiotics [2].
Our case also highlights the diagnostic role of molecu-
lar methods for these infections in routine laboratories
for rapid management and better patient outcome. The
role of solid culture in identifying presence of dual infec-
tion, which would have been otherwise missed on liquid
culture alone, is also important in this case, as previously
reported from our center [9].
In conclusion, the diagnosis of NTM infection and
the possibility of it occurring along with MTBC infec-
tion require a high index of suspicion on the part of the
ophthalmologist and a rapid and reliable diagnosis on
the part of the microbiologist. The use of immunosup-
pressant drugs, atypical features, and poor response to
ATT are important clinical pointers towards this rare
condition. Confirmatory evidences can be obtained
from growth on solid culture media followed by
appropriate molecular tests. A delay in diagnosis could
lead to irreversible damage as was seen in our case, and
thus, prompt initiation of multidrug therapy is often
needed. Although our patient lost his vision of one eye,
the relatively rapid diagnosis and timely institution of
oral levofloxacin (third-generation flouroquinolones),
along with stoppage of oral steroids, helped in prevent-
ing the dissemination of the infection in the body as
was shown by the absence of uptake of FDG in various
parts of the body on PET scan.
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